Publications
Publications
- August 2008 (Revised May 2009)
- HBS Case Collection
Note on Generic Drugs in the European Union
By: Robert C. Pozen and Elizabeth M. Leonard
Abstract
Rules governing the introduction of generic drugs in U.S. and EU have some similarities but significant differences because of the Hatch-Waxman Act in the U.S.
Keywords
Governing Rules, Regulations, and Reforms; Government Legislation; Health Care and Treatment; Trademarks; Brands and Branding; Pharmaceutical Industry; European Union; United States
Citation
Pozen, Robert C., and Elizabeth M. Leonard. "Note on Generic Drugs in the European Union." Harvard Business School Background Note 309-019, August 2008. (Revised May 2009.)